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Abstract
Background: Since 2010 Veneto region (North-Eastern Italy) planned a special integrated surveillance of summer
fevers to promptly identify cases of West Nile Fever (WNF), dengue (DENV) and chikungunya (CHIKV). The objectives
of this study were (i) To increase the detection rate of imported CHIKV and DENV cases in travellers from endemic
areas and promptly identify potential autochthonous cases.(ii) To detect autochthonous cases of WNF, besides
those of West Nile Neuroinvasive Disease (WNND) that were already included in a national surveillance.
Methods: Human surveillance: a traveler who had returned within the previous 15 days from endemic countries,
with fever >38°C, absence of leucocytosis (leukocyte count <10,000 μL), and absence of other obvious causes of
fever, after ruling out malaria, was considered a possible case of CHIKV or DENV. A possible autochthonous case of
WNF was defined as a patient with fever >38°C for <7 days, no recent travel history and absence of other obvious
causes of fever. Entomologic surveillance: for West Nile (WNV) it was carried out from May through November
placing CDC-CO2 traps in five provinces of Veneto Region, while for DENV and CHIKV it was also performed around
residences of viremic cases.
Results: Human surveillance: between 2010 and 2012, 234 patients with fever after travelling were screened, of
which 27 (11,5%) were found infected (24 with DENV and 3 with CHIKV). No autochthonous case of DENV or CHIKV
was detected. Autochthonous patients screened for WNF were 408, and 24 (5,9%) were confirmed cases.
Entomologic surveillance: the WNV was found in 10, 2 and 11 pools of Culex pipiens from 2010 to 2012 respectively,
in sites of Rovigo, Verona, Venezia and Treviso provinces). No infected Aedes albopictus with DENV or CHIKV was
found.
Conclusions: Veneto is the only Italian region reporting WNV human cases every year since 2008. WNV is likely to
cause sporadic cases and unforeseeable outbreaks for decades. Including WNF in surveillance provides additional
information and possibly an early alert system. Timely detection of DENV and CHIKV should prompt vector control
measures to prevent local outbreaks.
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Background
In Italy, the first outbreak of West Nile virus (WNV) in-
fection was reported in 1998 among horses residing in
Tuscany region [1]. The virus re-emerged in Italy in 2008,
when equine and human cases of West Nile neuroinvasive
disease (WNND) were notified in Veneto and Emilia
Romagna Regions [2,3].
Moreover, veterinary and entomological surveillance
documented that WNV infection was widespread in the
same areas in North-Eastern Italy, with notification of 251
outbreaks in equine stables and viral isolation in resident
bird species [4].
Autochthonous cases of chikungunya (CHIKV) in Europe
were reported in the well known outbreak in Emilia
Romagna in 2007 [5] and in France in 2010 [6]. Au-
tochthonous cases of dengue (DENV) in Europe were
reported in 2010 in France [6,7] and in Croatia [8,9]
while in 2012 a large outbreak occurred in the island of
Madeira (Portugal) [10].
So far no autochthonous cases of DENV and CHIKV
have been reported in Veneto region, but the presence
of Ae. albopictus highlights the potential risk of out-
break following the introduction of a viremic host. This
mosquito species, after the first report in Italy (Genoa,
Liguria region) in 1990 [11], was then reported in Veneto
in 1991 and rapidly spread to the whole territory of the
region [12] (Figure 1).
In view of the appearance of human WNV in our Region
on one side, and of the established and massive presence of
Ae. albopictus on the other, since 2010 Veneto Region
(North-Eastern Italy) has planned a special integrated sur-
veillance of summer fevers to promptly identify cases of
West Nile Fever (WNF), DENV and CHIKV.
Before the onset of special surveillance, in 2008 one
case of CHIKV, two cases of DENV (all imported) and 1
case of WNND had been reported; four more cases of
WNND and one case of West Nile Fever (WNF) had
been identified retrospectively [3,13] (Table 1).
In 2009 four cases of imported DENV and 6 cases of
WNND (one fatal) had been reported [14], with no case
of CHIKV nor of WNF.
The success of the pilot phase in 2010 [15] prompted
the Regional authorities to extend the project to two more
years (2011-2012), as part of the integrated surveillance of
arboviral diseases, along with veterinary and entomologic
surveillance.
Figure 1 Distribution of Ae. albopictus in Veneto region, according to the year of first detection.




The main objectives of human surveillance were:
a) To increase the detection rate of imported CHIKV
and DENV cases in travellers from endemic areas,
including new immigrants and settled immigrants
visiting relatives and friends (VFR), and to promptly
identify potential autochthonous cases;
b) To detect autochthonous cases of WNF, along with
those of WNND already included in regular
surveillance, in order to obtain a more reliable
picture of the disease transmission in the region.
The main objectives of entomological surveillance were:
c) To detect DENV or CHIKV in Ae. albopictus
vectors, in case of the report of a viremic human
case of DENV or CHIKV;
d) to predict the WNV circulation in the area through
the search of the virus in Culex pipiens vectors.
Human surveillance
Case definition are reported in Figures 2 and 3. A trav-
eler who had returned within the previous 15 days from
endemic countries for DENV or CHIKV, with fever >38°C,
absence of leucocytosis (leukocyte count <10,000 μL),
and absence of other obvious causes of fever, after ruling
out malaria, was considered a possible case of DENV or
CHIKV.
If rapid tests for DENV or CHIKV resulted positive,
the patient was considered a probable case. Rapid tests
included detection of anti-CHIKV IgM with the OnSite
Chikungunya IgM Combo Rapid Test (CTK Biotech,
Inc., San Diego, CA, USA), anti-DENV IgM and IgG
with the Dengue Quick test (Cypress Diagnostics,
Langdorp, Belgium) and of DENV nonstructural pro-
tein (NS) 1 antigen with the Dengue NS1 Ag STRIP
(Bio-Rad Laboratories, Hercules, CA, USA) on serum
samples. Confirmed cases were defined as the presence
of viral nucleic acid in blood specimens or by serocon-
version or detection of increasing serum levels of spe-
cific IgM and IgG.
Table 1 Cases of the three diseases notified in Veneto Region, 2008-2012








2010* 14/79 (17.7%) 1/79 (1.2%) 4/38 (10.5%) 3
2011 3/29 (10.3%) 0/29 (0%) 3/51 (5.8%) 10
2012# 7/126 (5.5%) 2/126 (1.5%) 17/319 (5.3%) 21
TOT 2010-2012 24/234 (10.2%) 3/234 (1.2%) 24/408 (5.9%) 34
*Surveillance only started the last week of July. #Surveillance was prolonged until 30th of November.
Figure 2 Algorithm for detection of possible cases of West Nile Fever, Veneto Region, since 2011. N, no; Y, Yes; WNND, West Nile
neuroinvasive disease; neg, negative; pos, positive.
Gobbi et al. BMC Infectious Diseases 2014, 14:60 Page 3 of 9
http://www.biomedcentral.com/1471-2334/14/60
Second-line laboratory testing consisted of detection
of DENV and CHIKV nucleic acids in plasma specimens
by using real-time PCR and endpoint PCR, respectively,
and detection of serum IgM and IgG by using an anti-
CHIKV indirect immunofluorescence assay (Euroimmun
AG, Lübeck, Germany), DENV IgG DxSelect (Focus Diag-
nostics, Cypress, CA, USA), and DENV IgM Capture
DxSelect (Focus Diagnostics). Samples with DENV positive
results by ELISA were further tested by plaque-reduction
neutralization test to confirm specificity of antibody
response.
A possible autochthonous case of WNF was defined as
a patient with fever >38°C for <7 days, age >15 years, no
recent travel history and absence of other obvious causes
of fever.
A probable case was defined as a patient with a positive
first-line laboratory test. The latter included detection of
IgM and IgG antibodies against WNV in serum and CSF
samples, with ELISA (WNV IgM capture DxSelect ELISA
and IgG DxSelect ELISA kits, Focus Diagnostics, Cypress,
California). A confirmed case was defined as a patient with
at least one of the following laboratory criteria: isolation of
WNV from blood; detection of WNV RNA by RT-PCR
in blood; detection of increasing levels of IgM and IgG
antibodies against WNV by ELISA, confirmed by plaque-
reduction neutralisation test (PRNT).
Entomologic surveillance
Entomologic surveillance for West Nile was carried out
from May through November placing CDC-CO2 traps in
five provinces of the region (Figure 4). Mosquitoes were
collected fortnightly, identified, pooled in up to 50 speci-
mens and tested using a One-Step SYBR Green-based
Reverse Transcriptase-Real-Time PCR [16]. Amplicons
were directly sequenced and positive samples confirmed
by the National Reference Centre for Exotic Diseases
(CESME, Istituto G. Caporale, Teramo).
Entomologic surveillance was also performed in areas
surrounding the residence of human cases of DENV and
CHIKV, if notified as viremic. In this case BG-sentinel
traps with BG-Lure attractant (a mosquito attractant
that mimics human skin odour) were used to capture
adults of Ae. albopictus. Mosquitoes were counted, iden-
tified, frozen (-80°C) and sent to the National Arbovirus
laboratory in Rome for virus examination.
Statistical analysis
The mean abundance of mosquitoes per traps was com-
pared among years using analysis of variance (ANOVA),
after loge(x + 1) transformation of the data. The rates of
infection in mosquitoes were adjusted for pooled sam-
ples calculating the estimated rate of infection (ERI), ac-
cording to Cowling et al. [17]. For the 2012 season only,
when a higher number of human cases was reported,
the vector index was calculated for 2-week time steps
by using abundance (numbers per trap per night) of the
traps located in a radius of 25 km from the positive/s
traps and ERI for Cx. pipiens mosquitoes [18]. For the
calculation of the vector index a trap of the neighbouring
region (Friuli Venezia Giulia) was also included due to
landscape homogeneity and trap proximity with human
cases. The vector index was correlated with the human
cases using linear regression. The software used was
SPSS for Windows, version 13.0.
Ethical approval
This paper describes the results of a surveillance program
put in place by health authorities of the Region and was
Figure 3 Algorithm for management of possible cases of dengue and chikungunya, Veneto Region, since 2011. Neg, negative; pos, positive.
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not primarily intended as a research project. For this rea-
son a formal ethical clearance was not required. Patient
data are fully anonimized and no specific activity on hu-
man subjects was undertaken, other than that planned as
regular surveillance activity and patient clinical manage-
ment according to usual practice.
Results
Human surveillance
The main results are summarised in Table 1. In the 3 years
of surveillance, between 2010 and 2012, 234 patients with
fever after travelling were screened, of which 27 (11,5%)
were found infected (24 with DENV and 3 with CHIKV).
No autochtonous case was detected. Autochtonous pa-
tients screened for WNF were 408, and 24 (5,9%) were
found infected. Some relevant details of the patients are
reported in Table 2. Most patients with WNF (22/25, 88%)
were hospitalized. No severe case of DENV (DHF, DSS)
nor of CHIKV were observed. The median diagnostic
delay since the onset of symptoms was 14 days for DENV
(range 2-37), 17 days for CHIKV (range 16-19), 23 days
for WNF (range 6-66).
Entomologic surveillance
The number of traps activated in the three years and the
results of entomologic surveillance for WN are summa-
rized in Table 3. Seventeen species of mosquitoes were
identified, and Cx. pipiens accounted for more than 80%
of mosquitoes collected.
The WNV was found in 10, 2 and 11 pools of Cx.
pipiens from 2010 to 2012 respectively, in sites of Rovigo,
Verona, Venezia and Treviso provinces (Figure 4), areas
where viral circulation was known, on the basis of human
and veterinary cases detected in the previous years.
Despite the drought, the year 2012 was characterized by
a significantly higher abundance of Cx pipiens compared
to the two previous years (Table 3).
The vector index ranged from 0.25 to 0.67 and was
correlated with the increasing number of human cases
reported in the following 15 days (R = 0.843, p < 0.01),
including WNF, WNND and asymptomatic donors
(Figure 5). In particular, single human cases were not
or rarely predicted by the vector index, while clusters
of cases (>2) were predicted by a vector index of ≥ 0.5
until the third week of August and by a vector index
Figure 4 Maps showing the relative density of Cx. pipiens, the mosquito traps activated and positive for WNV and the municipalities
with human cases (WNF, WNND and donors) in 2010, 2011 and 2012.
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of ≥ 0.25 later in the season. Entomologic surveillance
for Ae.albopictus was performed following three reports of
dengue fever in Vicenza (June 26th) and Verona provinces
(August 26th and September 7th) in 2011. Adults cap-
tured were 10, 22 and 7, respectively and all resulted
negative for the virus. In 2012, two dengue viremic
cases were notified (August 29th and October 12th),
however entomological surveillance was not required
due to adverse weather conditions not compatible with
Ae. albopictus presence in the respective sites.
Discussion
In summary, during the three years period of the study
we found 24 cases of DENV, 3 cases of CHIKV, 24 cases
of WNF. All survived. The proportion over all subjects
screened was 10.2% for DENV, 1.2% for CHIKV, 5.9% for
WNF. While no Aedes albopictus adult was found infected
with DENV or CHIKV, pools of Culex pipiens infected
with WNV were found in 4 of the 7 provinces of the
region.
The recent major outbreak of dengue in Madeira island
(Portugal) [10], the previous local transmission of DENV
documented in France [6,7], in Croatia [8,9] and the out-
break of CHIKV in Emilia Romagna in 2007 [5] highlight
the importance of surveillance of imported cases in order
to prevent or limit local transmission.
It is of note that PCR resulted positive in 15/24 (62%)
of DENV cases in our series (Table 2): early detection
in humans (that also allowed the identification of the
serotype) prompted, when/where indicated, entomologic
surveillance for Ae. albopictus to test the adults for viral
presence, although none resulted positive.
Veneto is the only Italian region that has reported
WNV human cases every year since 2008. In the whole
country the data aren’t homogeneous [19,20]. The first
human cases were reported in Veneto and in Emilia
Romagna in 2008 [2,3], although a retrospective study
revealed a human case in Tuscany in 2007 [21].
In 2011 two more regions, Sardinia and Friuli-Venezia
Giulia, reported WNND cases [19] and one region, Marche,
reported a WNF case [22]. If surveillance was limited to
WNND, we would be completely unaware of the virus cir-
culation in the latter region. Moreover the viral circulation
had been documented to occur in many areas of Italy
from North to South through retrospective screening of
solid organ donors and through entomologic and veterin-
ary surveillance [23].
Based on our findings, we suggest that surveillance
should also include WNF in order to provide additional
information on the viral circulation in humans and con-
tribute to an early alert system.
Before the special surveillance, in two years time since
the beginning of the outbreak of autochthonous WNV
disease, only one retrospective case of WNF had been
reported, in spite of the expected proportion WNF/
WNND of 20/1, according to the literature [24]. It is
worth noting that recent studies [25,26] suggest that the
proportion of symptomatic patients is even higher than
previously reported [25]. WNF is therefore the most
common clinical presentation of West Nile disease, al-
though many WNF cases remain undiagnosed. Patients








Time from symptom onset
to diagnosis, (range) days
Positivity of PCR and/or
viral isolation
Sero type Adm. to
hospital
DENV 24 14/10 38 (17-64) America
(7)
14 (2-37) 15/24 (62%) 1 (5 cases) n.a.
Asia (15) 2 (3 cases)
Africa (1) 3 (5 cases)
Europe (1)
CHIKV 3 1/2 29 (13-58) Asia (3) 17 (16-19) 0/3 (0%) - n.a.
WNF 24 18/6 59 (29-80) Italy (24) 23 (6-66) 4/24 (17%) - 22/25 (88%)
Table 3 CO2 traps activated from 2010 to 2012 in Veneto region, mosquitoes collected, WNV positive pools and





Cx pipiens (%) mean Cx pipiens/capture WNV pos pools ERI min-max WNV pos sites
2010 43 137,848 86.9 249.9 10 0.056-2.174 4
2011 48 79,410 81.4 113.9 2 2.322-2.535 2
2012 24 104,930 74.7 291.3 11 0.052-0.946 5
Total 115 322,188 81.6 199.9 23 0.052-2.535 9
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with “simple” WNF should be monitored clinically to
avoid the onset of complications, also remembering that
WNF cases not evolving in WNND aren’t necessarily be-
nign [27]. Moreover the epidemiology of WNV trans-
mission is unpredictable. In United States in 2012, the
largest outbreak ever recorded was observed, after years
of relative quiescence. Petersen and Fischer consider
WNV “unpredictable, disagreeable and difficult to con-
trol”, suggesting that “WNV will cause sporadic cases
and big and small unforeseeable outbreaks for decades
to come” [28]. For this reason they recommend a timely
surveillance on a large scale in animals, insects and
people.
In Veneto the entomological surveillance was useful
(i) to define the mosquito species composition and relative
density all over the region, indicating the area at major
risk of WNV life cycle amplification, which are the main
targets of the control strategies and (ii) to indicate Cx.
pipiens as the main vector of WNV in this area.
The vector index showed to be correlated with the in-
creasing number of human cases, indicating that it can
be used as a predictor of clusters of cases in the surround-
ing areas within two weeks. However sporadic cases in
humans (WNF and asymptomatic blood donors) have
preceded detection in mosquitoes (Figure 5).
A clear vector index threshold was not identified and
more data are needed before drawing any conclusion. In
this respect, a more intensive entomological surveillance
on a 1-week step has been scheduled for the next mosquito
season in the area where the majority of human cases have
been reported.
Interestingly, the 2012 upsurge of WNV human cases
was found in a year characterized by a strong drought,
which did not cause a decrease of mosquito population,
likely due to the artificial irrigation in this area strongly
devoted to corn production. The concentration of larval
breeding sites closer to human settlement caused by the
irrigation and the contemporary presence of synantropic
birds able to act as reservoir of WNV may have caused
an increased contact between humans and infected
mosquitoes.
The major strengths of this surveillance project are the
good integration of human and entomologic surveillance
and the ability to provide a sufficiently comprehensive pic-
ture of the occurrence of these three arboviruses of human
interest in our region.
The project had some limitations, too. A major weakness
is the low number of WNF cases compared to WNND.
The main reason is that most mild cases do not seek med-
ical advice and, if they do, are seldom referred to hospital
Figure 5 Relationship between vector index and human cases reported in the 15 days following the record of a WNV positive trap in
2012. The day of the onset of symptoms and the day of donation were considered for WNF/WNND and donors, respectively. When human cases
are reported in the absence of mosquito positivity, a vector index = 0 in the closest trap in the previous two week has been reported.
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or to a laboratory. The cases detected are therefore the tip
of the iceberg and, not surprisingly, were almost all admit-
ted. Also, the total number of febrile patients returning
from endemic countries and screened for DENV and
CHIKV is comparatively low. Moreover, as most of them
come from countries where malaria also occurs, it is clear
that all these patients should promptly referred to skilled
diagnosis, which is not always the case. In order to deal
with both weaknesses, a better involvement of family doc-
tors in surveillance is clearly crucial.
Future research should focus on the sustainability of this
surveillance program, including a thorough cost analysis,
in order to be able to recommend its adoption as a routine
surveillance system and its diffusion to other regions.
Conclusions
WNV is likely to cause sporadic cases and unforeseeable
outbreaks for decades. Including WNF in regular sur-
veillance provides a more comprehensive picture of WNV
circulation in humans. Timely detection of DENV and
CHIKV should prompt vector control measures and
contribute to prevent local outbreaks.
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